Sulfonamides (SAs), widely used in human and veterinary medicine, enter the environment through metabolism and accumulate in marine ecosystems, affecting both marine ecosystems and human health. However, there is a lack of systematic research in China regarding the relationship between the usage inputs of SAs and their marine fate. This study presented a comprehensive analysis of data regarding SAs in the marginal seas of China and the usage of SAs from 2009 to 2020 what we can collect, focusing on the distribution and fate of SAs in China's marginal seas. Results supported by restrictive data indicated 22 types of SAs in seawater and 17 in sediments, with sulfamethoxazole and trimethoprim being the two primary SAs. Total SAs concentration in seawater ranged from 0.12 ng/L to 309.71 ng/L, while in sediments it ranged from 0.07 ng/g to 360.4 ng/g, with the Bohai Sea being the most severely polluted marine area by SAs in China. SAs residues varied significantly by year, ranging from 3 tons to 242 tons in the Bohai Sea and from 7 tons to 316 tons in the Yellow Sea. It is noteworthy that the residues of SAs in both the Bohai Sea and Yellow Sea have markedly decreased in recent years, reflecting reduced pollution levels likely attributed to factors such as reduced usage of SAs due to national regulatory measures. This study holds significant scientific value for systematically understanding the status of SAs in China's marginal seas, as well as for formulating strategies for the use, emission, and pollution management of emerging contaminants including SAs.
扫码关注我们
求助内容:
应助结果提醒方式:
